209 related articles for article (PubMed ID: 25630346)
21. Is tightly controlled disease activity possible with online patient-reported outcomes?
Walter MJ; Mohd Din SH; Hazes JM; Lesaffre E; Barendregt PJ; Luime JJ
J Rheumatol; 2014 Apr; 41(4):640-7. PubMed ID: 24532833
[TBL] [Abstract][Full Text] [Related]
22. Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort.
Yang G; Bykerk VP; Boire G; Hitchon CA; Thorne JC; Tin D; Haraoui B; Keystone EC; Pope JE;
J Rheumatol; 2015 Jan; 42(1):46-54. PubMed ID: 25399388
[TBL] [Abstract][Full Text] [Related]
23. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
Sokka T; Kautiainen H; Toloza S; Mäkinen H; Verstappen SM; Lund Hetland M; Naranjo A; Baecklund E; Herborn G; Rau R; Cazzato M; Gossec L; Skakic V; Gogus F; Sierakowski S; Bresnihan B; Taylor P; McClinton C; Pincus T;
Ann Rheum Dis; 2007 Nov; 66(11):1491-6. PubMed ID: 17412740
[TBL] [Abstract][Full Text] [Related]
24. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?
Putrik P; Ramiro S; Kvien TK; Sokka T; Uhlig T; Boonen A;
Ann Rheum Dis; 2014 Nov; 73(11):2010-21. PubMed ID: 23940213
[TBL] [Abstract][Full Text] [Related]
25. Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis.
El-Zorkany B; Mokbel A; Gamal SM; Mousa M; Youssef M; Hmamouchi I
Clin Rheumatol; 2016 May; 35(5):1153-9. PubMed ID: 26670453
[TBL] [Abstract][Full Text] [Related]
26. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
Sokka T; Toloza S; Cutolo M; Kautiainen H; Makinen H; Gogus F; Skakic V; Badsha H; Peets T; Baranauskaite A; Géher P; Ujfalussy I; Skopouli FN; Mavrommati M; Alten R; Pohl C; Sibilia J; Stancati A; Salaffi F; Romanowski W; Zarowny-Wierzbinska D; Henrohn D; Bresnihan B; Minnock P; Knudsen LS; Jacobs JW; Calvo-Alen J; Lazovskis J; Pinheiro Gda R; Karateev D; Andersone D; Rexhepi S; Yazici Y; Pincus T;
Arthritis Res Ther; 2009; 11(1):R7. PubMed ID: 19144159
[TBL] [Abstract][Full Text] [Related]
27. The effect of different remission definitions on identification of predictors of both point and sustained remission in rheumatoid arthritis treated with anti-TNF therapy.
Barnabe C; Homik J; Barr SG; Martin L; Maksymowych WP
J Rheumatol; 2014 Aug; 41(8):1607-13. PubMed ID: 25028371
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.
Choy EH; Khoshaba B; Cooper D; MacGregor A; Scott DL
Arthritis Rheum; 2008 Feb; 59(2):192-9. PubMed ID: 18240256
[TBL] [Abstract][Full Text] [Related]
29. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
30. Contribution of the subjective components of the disease activity score to the response to biologic treatment in rheumatoid arthritis.
Jurgens MS; Overman CL; Jacobs JW; Geenen R; Cuppen BV; Marijnissen AC; Bijlsma JW; Welsing PM; Lafeber FP; van Laar JM;
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):923-8. PubMed ID: 25504811
[TBL] [Abstract][Full Text] [Related]
31. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.
Nikiphorou E; van der Heijde D; Norton S; Landewé RB; Molto A; Dougados M; Van den Bosch FE; Ramiro S
Ann Rheum Dis; 2018 Mar; 77(3):405-411. PubMed ID: 29222349
[TBL] [Abstract][Full Text] [Related]
32. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
Radovits BJ; Fransen J; van Riel PL; Laan RF
Ann Rheum Dis; 2008 Aug; 67(8):1127-31. PubMed ID: 17965425
[TBL] [Abstract][Full Text] [Related]
33. Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
Bengtsson K; Jacobsson LT; Rydberg B; Kvist G; Torstenson T; Dehlin M; Hilme E; Lindhé A; Wallerstedt SM; Forsblad-d'Elia H
BMC Musculoskelet Disord; 2016 Dec; 17(1):499. PubMed ID: 27955647
[TBL] [Abstract][Full Text] [Related]
34. Disease activity score-28 values differ considerably depending on patient's pain perception and sex.
Leeb BF; Haindl PM; Maktari A; Nothnagl T; Rintelen B
J Rheumatol; 2007 Dec; 34(12):2382-7. PubMed ID: 17985407
[TBL] [Abstract][Full Text] [Related]
35. Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
Thiele K; Huscher D; Bischoff S; Späthling-Mestekemper S; Backhaus M; Aringer M; Kohlmann T; Zink A;
Ann Rheum Dis; 2013 Jul; 72(7):1194-9. PubMed ID: 22915625
[TBL] [Abstract][Full Text] [Related]
36. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.
Sokka T; Kautiainen H; Pincus T; Verstappen SM; Aggarwal A; Alten R; Andersone D; Badsha H; Baecklund E; Belmonte M; Craig-Müller J; da Mota LM; Dimic A; Fathi NA; Ferraccioli G; Fukuda W; Géher P; Gogus F; Hajjaj-Hassouni N; Hamoud H; Haugeberg G; Henrohn D; Horslev-Petersen K; Ionescu R; Karateew D; Kuuse R; Laurindo IM; Lazovskis J; Luukkainen R; Mofti A; Murphy E; Nakajima A; Oyoo O; Pandya SC; Pohl C; Predeteanu D; Rexhepi M; Rexhepi S; Sharma B; Shono E; Sibilia J; Sierakowski S; Skopouli FN; Stropuviene S; Toloza S; Valter I; Woolf A; Yamanaka H;
Arthritis Res Ther; 2010; 12(2):R42. PubMed ID: 20226018
[TBL] [Abstract][Full Text] [Related]
37. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
Aletaha D; Smolen JS
Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
[TBL] [Abstract][Full Text] [Related]
38. The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis.
Miwa Y; Furuya H; Yanai R; Kasama T; Sanada K
Intern Med; 2017 Dec; 56(23):3167-3172. PubMed ID: 29021442
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.
Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
Rheumatol Int; 2015 Nov; 35(11):1851-5. PubMed ID: 26238094
[TBL] [Abstract][Full Text] [Related]
40. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G
Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
